Will Canopy Growth Return to $60?

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has fallen more than 30% in just the past three months, but whether it’ll be able to recover will depend on several factors.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has fallen hard over the past few months. The stock used to have very strong support at $60, then at $50, but now, it’s not certain whether it will have any even at the $40 mark.

The reality is that cannabis stocks have been hit very hard this year, and although Canopy Growth as of Monday’s close was still up over 20% since the start of the year, those gains may not last for much longer.

There’s a lot of noise right now impacting cannabis stocks, which makes it very difficult  to determine where a stock like Canopy Growth might go. The worse the CannTrust situation becomes, the more stocks in the industry will suffer as a result, even if they have no issues of their own growing cannabis illegally.

Investors simply have a lack of trust in the industry, which alone could be enough to weigh down otherwise strong cannabis stocks. At minimum, it could take weeks or even months for the industry to recover from the fallout.

As well, stocks like Canopy Growth are feeling pressure to do a better job of meeting expectations. With a greater focus on profitability instead of just sales growth, it’s just not as easy for cannabis companies to provide projections of where they’ll be tomorrow.

Clearly, the honeymoon phase for the industry is over, and the results can’t simply be brushed aside anymore. A good example of that is Canopy Growth’s own situation, where a lack of profitability was likely the catalyst behind Bruce Linton being let go by the company.

With the financials not being very strong and the cannabis industry seeing a lot of bearish activity lately, the outlook for Canopy Growth’s stock doesn’t look good today. The reality of the situation is that the stock has been overvalued for a long time and a correction was long overdue.

As lucrative as the industry may be in terms of growth projections, companies still need to be profitable to be good investments, and that simply hasn’t been the case thus far. Strong sales growth won’t be enough for investors to pay big premiums, whether for Canopy Growth or any other stock.

Why Canopy Growth could still return to $60

For all of the reasons that Canopy Growth could fall to below $40, there are also a couple of big reasons why it could rally as well.

If the company’s change in leadership results in a stronger bottom line, it could be enough to get investors more bullish about the stock.

While the company may not have its visionary anymore, Canopy Growth is already well positioned to take advantage of many developments in the industry, including moves south of the border into a lucrative U.S. market.

Losing Linton may therefore not hurt the company’s aggressive growth strategy, at least, not in the near term.

There’s also the possibility that the edibles market, and beverages specifically, do well enough that they generate some momentum in Canopy Growth’s stock as well.

Overall, I wouldn’t be surprised to see the stock return back to $60, but without a major development, it might not happen until sometime next year.

Should you invest $1,000 in Canopy Growth right now?

Before you buy stock in Canopy Growth, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Canopy Growth wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »